Danone Q1 2026 slides: growth resilient despite currency headwinds

Danone reported Q1 2026 sales of €6.7 billion, with like-for-like growth of 2.7% driven by 1.5% volume/mix and 1.2% pricing, but reported sales fell year over year due to a 5.6% negative currency impact. Asia Pacific led growth at 6.0%, while EMEA was held back by an infant formula recall and Middle East disruptions; the company reaffirmed full-year 2026 guidance for 3% to 5% LFL sales growth. Danone also announced two strategic deals in March, including the planned acquisition of Huel and a dairy transaction in Argentina, both expected to close in 2H 2026.

Analysis

The key market read is that Danone is proving it can still print mid-single-digit underlying growth while absorbing a lot of exogenous noise, which should support a relative-value rerating versus slower-growing staples peers. The second-order issue is that FX is now the dominant headline drag, so investors may be underestimating how much earnings leverage reappears if the euro stabilizes or weakens into H2; that can matter more than incremental volume beats over the next 2-3 quarters.

The more interesting strategic signal is the portfolio tilt: management is shifting toward higher-velocity, health-positioned nutrition assets while pruning geographic and category friction. That should improve mix and pricing power over 12-24 months, but it also raises execution risk because integration and regulatory close timelines can create a gap between narrative and P&L, especially if U.S. competitive pressure persists and the EMEA recall lingers into the next reporting cycle.

Consensus appears to be focused on the near-term top-line resilience, but the overhang is that geopolitics and FX can mask whether organic demand is actually inflecting or just being protected by pricing. If the Middle East environment de-escalates and supply chain normalization follows, the bounce in reported sales can be sharp; if not, the market may start discounting a low-teens multiple on more stable but not accelerating growth. The contrarian setup is that the stock can work even without a big growth upgrade, simply on margin durability and a reduction in perceived operational risk once the recall and geopolitical disruptions fade.

Key Decisions for Investors

• Go long DANO.PA on pullbacks over the next 2-6 weeks; the risk/reward is attractive if FX stops being a headwind, with potential for a 5-10% rerating on any H2 guidance confidence.
• Pair trade: long DANO.PA / short a more FX-sensitive European staples peer with weaker mix and higher EM exposure; thesis is that Danone’s health/nutrition tilt deserves a premium while peers remain more exposed to euro strength.
• Buy 3-6 month call spreads on DANO.PA rather than outright stock if available liquidity supports it; the upside is a re-rating on margin durability, while downside is limited if the recall or MENA disruptions persist.
• Use any post-earnings strength to fade overbought European food names that have less pricing power; Danone’s relative resilience makes it a cleaner long versus lower-quality defensives.
• Monitor the euro and USD/CNY closely; if FX turns, add to the long because reported growth can accelerate faster than consensus expects, creating a favorable revision cycle over the next 1-2 quarters.